Stryker saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 64 to 71.
How To Invest In Stocks In Both Bull And Bear Markets
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
History reveals that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves. See if Stryker can continue to show renewed price strength and clear that threshold.
Stryker is trying to complete a consolidation with a 406.19 entry. See if the stock can clear the breakout price in heavy trade.
Earnings growth slowed last quarter from 16% to 14%. But sales moved higher, from 11% to 12%.
The company holds the No. 12 rank among its peers in the Medical-Products industry group. Insulet, Boston Scientific and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
